205 related articles for article (PubMed ID: 29063815)
1. N-acetyl-L-cysteine functionalized nanostructured lipid carrier for improving oral bioavailability of curcumin: preparation, in vitro and in vivo evaluations.
Tian C; Asghar S; Wu Y; Kambere Amerigos D; Chen Z; Zhang M; Yin L; Huang L; Ping Q; Xiao Y
Drug Deliv; 2017 Nov; 24(1):1605-1616. PubMed ID: 29063815
[TBL] [Abstract][Full Text] [Related]
2. Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers.
Tian C; Asghar S; Wu Y; Chen Z; Jin X; Yin L; Huang L; Ping Q; Xiao Y
Int J Nanomedicine; 2017; 12():7897-7911. PubMed ID: 29138557
[TBL] [Abstract][Full Text] [Related]
3. A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin.
Li J; Liu D; Tan G; Zhao Z; Yang X; Pan W
Carbohydr Polym; 2016 Aug; 146():435-44. PubMed ID: 27112894
[TBL] [Abstract][Full Text] [Related]
4. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
[TBL] [Abstract][Full Text] [Related]
5. Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin.
Liu D; Li J; Pan H; He F; Liu Z; Wu Q; Bai C; Yu S; Yang X
Sci Rep; 2016 Jun; 6():28796. PubMed ID: 27350323
[TBL] [Abstract][Full Text] [Related]
6. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.
Rashidzadeh H; Salimi M; Sadighian S; Rostamizadeh K; Ramazani A
Curr Drug Deliv; 2019; 16(10):923-930. PubMed ID: 31663477
[TBL] [Abstract][Full Text] [Related]
7. Galactosamine-modified PEG-PLA/TPGS micelles for the oral delivery of curcumin.
Sun S; Du X; Fu M; Khan AR; Ji J; Liu W; Zhai G
Int J Pharm; 2021 Feb; 595():120227. PubMed ID: 33484915
[TBL] [Abstract][Full Text] [Related]
8. Toxicity Reduction and Efficacy Promotion of Doxorubicin in the Treatment of Breast Tumors Assisted by Enhanced Oral Absorption of Curcumin-Loaded Lipid-Polyester Mixed Nanoparticles.
Wang N; Zhang Y; Liu H; Wang A; Ren T; Gou J; Zhang Y; Yin T; He H; Tang X
Mol Pharm; 2020 Dec; 17(12):4533-4547. PubMed ID: 33201717
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside improves physicochemical properties and bioavailability of curcumin-loaded nanostructured lipid carrier.
Vijayakumar A; Baskaran R; Maeng HJ; Yoo BK
Arch Pharm Res; 2017 Jul; 40(7):864-874. PubMed ID: 28712035
[TBL] [Abstract][Full Text] [Related]
10. Evaluation in vitro and in vivo of curcumin-loaded mPEG-PLA/TPGS mixed micelles for oral administration.
Duan Y; Zhang B; Chu L; Tong HH; Liu W; Zhai G
Colloids Surf B Biointerfaces; 2016 May; 141():345-354. PubMed ID: 26874910
[TBL] [Abstract][Full Text] [Related]
11. BSA Nanoparticles Modified with
Zhang S; Asghar S; Yu F; Chen Z; Hu Z; Ping Q; Shao F; Xiao Y
J Agric Food Chem; 2019 Aug; 67(33):9371-9381. PubMed ID: 31379162
[TBL] [Abstract][Full Text] [Related]
12. Cysteine-Functionalized Nanostructured Lipid Carriers for Oral Delivery of Docetaxel: A Permeability and Pharmacokinetic Study.
Fang G; Tang B; Chao Y; Xu H; Gou J; Zhang Y; Xu H; Tang X
Mol Pharm; 2015 Jul; 12(7):2384-95. PubMed ID: 25974386
[TBL] [Abstract][Full Text] [Related]
13. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.
Xie X; Tao Q; Zou Y; Zhang F; Guo M; Wang Y; Wang H; Zhou Q; Yu S
J Agric Food Chem; 2011 Sep; 59(17):9280-9. PubMed ID: 21797282
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
Lin M; Teng L; Wang Y; Zhang J; Sun X
Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
[TBL] [Abstract][Full Text] [Related]
15. Tocophersolan stabilized lipid nanocapsules with high drug loading to improve the permeability and oral bioavailability of curcumin.
Bapat P; Ghadi R; Chaudhari D; Katiyar SS; Jain S
Int J Pharm; 2019 Apr; 560():219-227. PubMed ID: 30776407
[TBL] [Abstract][Full Text] [Related]
16. A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's disease.
Meng F; Asghar S; Gao S; Su Z; Song J; Huo M; Meng W; Ping Q; Xiao Y
Colloids Surf B Biointerfaces; 2015 Oct; 134():88-97. PubMed ID: 26162977
[TBL] [Abstract][Full Text] [Related]
17. The enhancement of N-acetylcysteine on intestinal absorption and oral bioavailability of hydrophobic curcumin.
Zhang S; Asghar S; Yu F; Hu Z; Ping Q; Chen Z; Shao F; Xiao Y
Eur J Pharm Sci; 2020 Nov; 154():105506. PubMed ID: 32763460
[TBL] [Abstract][Full Text] [Related]
18. High drug payload curcumin nanosuspensions stabilized by mPEG-DSPE and SPC: in vitro and in vivo evaluation.
Hong J; Liu Y; Xiao Y; Yang X; Su W; Zhang M; Liao Y; Kuang H; Wang X
Drug Deliv; 2017 Nov; 24(1):109-120. PubMed ID: 28155567
[TBL] [Abstract][Full Text] [Related]
19. Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles.
Feng R; Song Z; Zhai G
Int J Nanomedicine; 2012; 7():4089-98. PubMed ID: 22888245
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
Dudhipala N; Janga KY; Gorre T
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
